Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Personal Narrative Jun 2019 PrEP and the Judgment of Prevention Samuel Dubin Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical. AMA J Ethics. 2019;21(6):E536-539. doi: 10.1001/amajethics.2019.536. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Personal Narrative Jun 2016 Recovery and Service: On Being a Physician with Mental Illness Mark Vonnegut, MD Physicians with a mental illness can have good, empathic relationships with their patients, even if patients know of their condition. AMA J Ethics. 2016;18(6):643-645. doi: 10.1001/journalofethics.2016.18.6.mnar1-1606. Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681. Case and Commentary Sep 2002 An Impaired Resident, Commentary 1 Erin Egan, MD, JD Virtual Mentor. 2002;4(9):256-259. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209. Case and Commentary Sep 2002 An Impaired Resident, Commentary 2 DeWitt C. Baldwin, Jr, MD Virtual Mentor. 2002;4(9):260-263. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209. Case and Commentary Dec 2006 Relief Organizations with Counseling Restrictions Robert D. Orr, MD Virtual Mentor. 2006;8(12):814-817. doi: 10.1001/virtualmentor.2006.8.12.ccas3-0612. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Personal Narrative Jun 2019 PrEP and the Judgment of Prevention Samuel Dubin Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical. AMA J Ethics. 2019;21(6):E536-539. doi: 10.1001/amajethics.2019.536.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Personal Narrative Jun 2016 Recovery and Service: On Being a Physician with Mental Illness Mark Vonnegut, MD Physicians with a mental illness can have good, empathic relationships with their patients, even if patients know of their condition. AMA J Ethics. 2016;18(6):643-645. doi: 10.1001/journalofethics.2016.18.6.mnar1-1606.
Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681.
Case and Commentary Sep 2002 An Impaired Resident, Commentary 1 Erin Egan, MD, JD Virtual Mentor. 2002;4(9):256-259. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209.
Case and Commentary Sep 2002 An Impaired Resident, Commentary 2 DeWitt C. Baldwin, Jr, MD Virtual Mentor. 2002;4(9):260-263. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209.
Case and Commentary Dec 2006 Relief Organizations with Counseling Restrictions Robert D. Orr, MD Virtual Mentor. 2006;8(12):814-817. doi: 10.1001/virtualmentor.2006.8.12.ccas3-0612.